MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Luo, Qifeng ^a   Li, Xiaoyu ^a   Gao, Yan ^a   Long, Yin ^a   Chen, Lei ^a   Huang, Yixiang ^a   Fang, Lin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Cyclin E1; MiR 497

Indexed keywords

CYCLINE; GLYCOPROTEIN E1; MICRORNA; MICRORNA 497; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

EID: 84885094791     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-95     Document Type: Article

References (19)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
2. Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004, 10(3):544-550. 10.1261/rna.5235104, 1370948, 14970398.
3. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nature reviews Cancer 2006, 6(4):259-269.
4. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113(6):673-676. 10.1016/S0092-8674(03)00428-8, 12809598.
5. Carlsson J, Davidsson S, Helenius G, Karlsson M, Lubovac Z, Andrén O, Olsson B, Klinga-Levan K. A miRNA expression signature that separates between normal and malignant prostate tissues. Cancer Cell Int 2011, 11(1):14. 10.1186/1475-2867-11-14, 3123620, 21619623.
6. Poell JB, van Haastert RJ, de Gunst T, Schultz IJ, Gommans WM, Verheul M, Cerisoli F, van Noort PI, Prevost GP, Schaapveld RQ, et al. A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability. PLoS One 2012, 7(8):e43569. 10.1371/journal.pone.0043569, 3425484, 22927992.
7. Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol 2012, 29(1):384-391. 10.1007/s12032-010-9797-4, 21258880.
8. Ozata DM, Caramuta S, Velazquez-Fernandez D, Akcakaya P, Xie H, Hoog A, Zedenius J, Backdahl M, Larsson C, Lui WO. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 2011, 18(6):643-655. 10.1530/ERC-11-0082, 3201061, 21859927.
9. Shen L, Li J, Xu L, Ma J, Li H, Xiao X, Zhao J, Fang L. miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 2012, 3(3):475-480. 3438749, 22969914.
10. Lehmann U, Streichert T, Otto B, Albat C, Hasemeier B, Christgen H, Schipper E, Hille U, Kreipe HH, Langer F. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010, 10:109. 10.1186/1471-2407-10-109, 2850898, 20331864.
11. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X, et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 2011, 17(7):1722-1730. 10.1158/1078-0432.CCR-10-1800, 21350001.
12. Rosenberg E, Demopoulos RI, Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL, Newcomb EW. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival. Hum Pathol 2001, 32(8):808-813. 10.1053/hupa.2001.26462, 11521224.
13. Nakayama N, Nakayama K, Shamima Y, Ishikawa M, Katagiri A, Iida K, Miyazaki K. Gene Amplification CCNE1 Is Related to Poor Survival and Potential Therapeutic Target in Ovarian Cancer. Cancer 2010, 116(11):2621-2634.
14. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002, 347(20):1566-1575. 10.1056/NEJMoa021153, 12432043.
15. Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, Capodanno A, Migaldi M, Masciullo V, Scambia G, Rossi G, et al. Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy. Cancer science 2009, 100(6):1026-1033. 10.1111/j.1349-7006.2009.01141.x, 19385967.
16. Han J-Y, Wang H, Xie Y-T, Li Y, Zheng L-Y, Ruan Y, Song A-P, Tian X-X, Fang W-G. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PloS one 2012, 7(11):e49296. 10.1371/journal.pone.0049296, 3504019, 23185313.
17. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20. 10.1016/j.cell.2004.12.035, 15652477.
18. Vohradsky J, Panek J, Vomastek T. Numerical modelling of microRNA-mediated mRNA decay identifies novel mechanism of microRNA controlled mRNA downregulation. Nucleic Acids Res 2010, 38(14):4579-4585. 10.1093/nar/gkq220, 2919720, 20371515.
19. Chu C, Zhao Z. MicroRNA in the molecular mechanism of the circadian clock in mammals. Front Biosci 2013, 18:441-446.